Patent holdings for IPC class A61K 31/4458

Total number of patents in this class: 440

10-year publication summary

65
62
52
56
56
48
39
20
20
7
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Ironshore Pharmaceuticals & Development, Inc.
36
25
Tris Pharma, Inc.
79
19
Ohemo Life Sciences Inc
23
18
Purdue Pharma L.P.
500
16
Gilrose Pharmaceuticals, LLC
17
15
InCarda Therapeutics, Inc.
40
13
Medisca Pharmaceutique Inc.
137
12
Zevra Therapeutics, Inc.
99
11
Provident Bank
40
10
Clexio Biosciences Ltd.
102
10
Noven Pharmaceuticals, Inc.
103
8
Pacira Pharmaceuticals, Inc.
110
8
Amneal Complex Products Research LLC
65
8
Neos Therapeutics, LP
24
7
Heron Therapeutics, Inc.
154
6
Cingulate Therapeutics LLC
17
5
Incept LLC
150
5
Inserm (institut National de La Sante et de La Recherche Medicale)
3366
5
KemPharm, Inc.
28
5
Purdue Pharma
68
5
Other owners 229